| Tag | Content |
|---|
EnhancerAtlas ID | HS091-24547 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr19:49850620-49851880 |
Target genes | | Number: 43 | Name | Ensembl ID |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CTCF | MA0139.1 | chr19:49851325-49851344 | TTCCTCCATCTGCTGGCCA | - | 6.57 | | PBX1 | MA0070.1 | chr19:49851114-49851126 | TTTGATTGATGT | - | 6.74 | | TFAP2C | MA0524.2 | chr19:49850995-49851007 | AGCCCCAGGGCA | + | 6.11 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_58754 | chr19:49827549-49861083 | Ly1 | | SE_60095 | chr19:49827676-49860875 | Ly4 | | SE_61272 | chr19:49828268-49861182 | HBL1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr19 | 49851722 | 49851816 | | chr19 | 49851050 | 49851462 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I049347 | chr19 | 49851201 | 49851370 |
|
Enhancer Sequence | CTGAGGAGGG TTGGCCGTGG GTGAGAAGTC GGAGGTGAGC TGGATCTCCA GCCTGTGCTG 60
CCTGAGCCCA CCAAATGCCG TCACCATCCC CACAGCTCTG GCCAGCTGTT CCACACAGTC 120
CACCCAGCAC TGGGCCTGAC TGCCACCCAT CGTCCCCACT CCTGCTTCTG CACCCAGTCC 180
CCTGCAGCCC TGCAGTCCTA CAGTCCCCAA CTCCCTGCCA CAACTCCCCC AACTCCATCC 240
TCACTGCCTC AGCCTCACCT CAGGCCTCCC ACCCTCACCC CAGCCTCCAA CCTCGCCTCT 300
CCAGTTCATC CCTCATGTGG CTCCAGACCT GCCCCTGACC CTCCCCTGGT CATGGCCCTC 360
CCATAGCTCC CCAGCAGCCC CAGGGCAAAG CTCACACCCC CTAGGCCTGG TCCTATATAG 420
AACAGGTGCT CATAAATGGT CAATGGATGG AAGAGTGAAT GAATGGGAAT CCACAGAGGT 480
CTTGTGGTTG ATGTTTTGAT TGATGTTTAT ATGGTGTGGC AGAGACTGCT ACGTGTTCAC 540
AAATCCTGGT TCCTTTACAC AGTGTGAAAC TACATTTCCC AGGCCGCTTT GCAGTTAGGT 600
GTGACCACAT GACTAAGTTC TGGCCAATGG GATGTGACCA GGCCTGAGAG TCGACACATC 660
CAAGTCAGAT TCCTAAAACC TCCTGCACAA TCTTGACTCT CTCCCTTCCT CCATCTGCTG 720
GCCAGATGCA GAGACTCCAT CAGCAGATTC TGAAGCCTTA GAAAATGGCA GAGCCACAAA 780
ATGGAAGGAG CCTGGATCCC CAAATCACTT GAGTCCAAGG CTCCTGCTGA ACCTACATTG 840
AAATGTTACA TGCAACTTAT CTGGCATTCA GTCCCTAAGA GTTAGGAGCT GTTTCTTCTA 900
ACAGTCGGCC CACTCCATCC TAGCCCAGGA GAAGCTCAAG CACAGAAATA AAATCTTTTC 960
CAAGTTCCTA GTATGCATCA CAAAGCCTAG TGAACAGTAG AAACTCAAAC ACGTTTGATA 1020
AATGAATGAA TGATGTCCTG GGGAGCTTTT CTGACCTTCC CAACTTGTCA CCCTATGACC 1080
TTCCAGTTCC TTTATGCTAG TAGTTCTCAA AGTACGGTCC CCAGACCAGC TGCATCAACG 1140
CACCTGGTAG CTTATTAGAA ATGCAAATTC TCAAGCCCCA CATCACATCT AGCAAATCAG 1200
AAAGCAATCT CTGTTTTAAG AAGCCCTTCA GATGATTCTG ATACATGCTA AAGTTTTAAA 1260
|
